C12N 2750/14251
Methods of production or purification of viral material
C12N2750/14251 (Methods of production or purification of viral material) appears on 2 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 5
- Assignees
- 8
- Inventors
- 6
- Latest grant
- 10 Dec 2013
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 3 |
By publication year.
Subgroups
Granted patents
Recent patents
- Erythroparvovirus compositions and methods for gene therapy16 Oct 2025US 2025/0320521 A1Synteny Therapeutics, Inc.
- Erythroparvovirus with a modified genome for gene therapy2 Oct 2025US 2025/0302994 A1Synteny Therapeutics, Inc.
- Erythroparvovirus with a modified capsid for gene therapy25 Sep 2025US 2025/0295810 A1Synteny Therapeutics, Inc.
- Infectious clone of human parvovirus b19 and methods3 Jun 2010US 2010/0136514 A1Government of the US, as represented by the Secretary, Department of Health and Human Services
- Infectious clone of human parvovirus B19 and methods12 Jan 2006US 2006/0008469 A1Government of the United States, as represented by the Secretary, Dept. of Health and Human Services
Most cited
By later US patents